Select Page
Challenges faced after being censored on a professional platform for discussing autoimmunity in severe covid-19.
  • Being censored or removed from a platform can lead to feelings of rejection and inadequacy. 0:23

  • LinkedIn played a crucial role in the individual’s work, research, and personal connections. 1:04

  • A post challenging the understanding of severe covid-19 as an autoimmune disease was censored on LinkedIn. 2:53

  • The individual published a peer-reviewed paper on the theory of autoimmunity against Ace2 in severe covid-19. 3:58

  • The scientific principles presented by the individual are gaining recognition and support in the scientific community. 4:15

Autoimmunity in COVID-19 research reveals potential autoimmune response to the virus, sparking concerns in the scientific community.
  • COVID-19 virus triggers autoantibodies to spike protein and ACE2, leading to autoimmune response. 4:45

  • Challenges in conducting research on autoantibodies due to cost and sample collection issues. 5:50

  • Study shows elevated levels of autoantibodies in convalescent and hospitalized COVID-19 patients. 7:06

  • Revealing COVID-19 as a potential autoimmune disease poses significant implications for the future. 8:01

  • Scientist struggles with speaking out against misinformation and censorship in the scientific community. 8:42

Challenges of expressing concerns about immune suppression in severe conditions amidst scientific censorship.
  • Analogizes severe COVID-19 treatment with rheumatic fever immune suppression. 9:08

  • Struggles with expressing concerns due to potential repercussions on social media platforms. 10:08

  • Finds solace in sharing views on Substack amidst scientific censorship challenges. 11:18

  • Expresses hope for finding answers regarding autoimmunity in COVID-19. 11:44

  • Urges for cautious optimism and research exploration in facing potential challenges ahead. 12:01